How HDM1002 interacts with common drugs and diabetes medications
This study tests how a new drug called HDM1002 interacts with common diabetes medications (metformin, empagliflozin) and other drugs like warfarin and valsartan. If you are a generally healthy adult (age 18-45) with a higher BMI, this trial helps ensure the new drug is safe when taken with other medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You need to be in good general health, with no major medical problems.
- Your weight must be at least 110 pounds, and your body mass index (BMI) between 24 and 35.
- You cannot have a personal or family history of certain thyroid cancers or related genetic conditions.
- You must not have had pancreatitis, gallbladder attacks, or serious hypoglycemia in the last 3 months.
- You cannot have any condition that increases bleeding risk or affects stomach absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a new medicine, HDM1005, may change the way the body absorbs or processes some common medications like metformin, atorvastatin, warfarin, and digoxin. It may help doctors understand if HDM1005 can be taken safely with other drugs.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
Hear when a new Overweight Subject trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.